WORCESTER, Mass., Sept. 22, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has recently increased its presence in the global marketplace through its branch office, Generex Biotechnology Corporation MENA, which has its offices in the exclusive Dubai Healthcare City complex in Dubai, United Arab Emirates. Since its inception in early 2008, Generex MENA has been busy filing marketing applications for the Company’s product line in over 25 countries. To date, approvals for the sale of the Company’s confectionary and ethical line of products have been achieved in a number of countries in the MENA region.
